HMW-HA

DRUG2 trials

Sponsors

Campus Bio-Medico University

Conditions

Chronic Obstructive Pulmonary DiseaseCovid19

Phase 2

Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance

CompletedNCT02674880

Campus Bio-Medico UniversityChronic Obstructive Pulmonary Disease

Start: 2016-03-31End: 2019-09-30Updated: 2020-01-28

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

CompletedNCT04830020

Campus Bio-Medico UniversityCovid19

Start: 2021-02-26End: 2021-09-30Updated: 2022-03-16

Related Papers

Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.

2021-02-0136 citations

Akute COPD-Exazerbationen: Positive Wirkung von inhalierter hochmolekularer Hyaluronsäure bei schwerer Ateminsuffizienz

Kompass Pneumologie2021-01-01